The Louisiana Senate has passed a bill to create a psychedelic-assisted therapy pilot program, using opioid settlement dollars to fund clinical trials aimed at developing alternative treatments such as psilocybin and ibogaine.
The legislation from Sen. Patrick McMath (R) cleared the chamber, with new amendments, in a unanimous vote of 37-0 on Wednesday.
“This concept, this new type of treatment, was brought to my attention by members who served as Navy SEALs and terror rescue men and saw combat and came home and struggled with with post-traumatic stress. And had it not been for this ibogaine treatment that they had to go down to Mexico to receive, they would not be here with us today,” McMath said ahead of the vote. “They would not be fathers. They would not be friends.”
“The results, not only in post-traumatic stress, but also in substance abuse disorder and chronic depression are are overwhelming—over 90 percent success success rate when it comes to both heroin and alcohol dependency,” he said. “Seventeen veterans per day in this country commit suicide. For every combat death, there are five veterans that commit suicide when they come home. If we don’t try to remove some of the regulatory pathways
Read full article on Marijuana Moment
